DIA 49th Annual Meeting Session Reports
Monday, June 24
View Session 119. Hot Topics in Statistics: Working Together Effectively to Transform Our Science
View Session 123. How Can Translational Medicine Fill The Gaps in Life Sciences Industries?
View Session 130. Translational Aspects from Preclinical Animal Toxicology Studies to Early Human Health Risk Assessment: Needs and Limitations
View Session 143. Key Multiplicity Issues in Clinical Trial
View Session 144. The Secret of Stellar Careers: Serendipity + Planning = Success
Tuesday, June 25
View Session 220. Biomarkers for Drug Development: How are we dealing with the challenges?
View Session 234. Strategies for the Development and Registration of Antibody Drug Conjugates
View Session 239. Student Forum: Getting a Job & Developing a Career
View Session 262. First-in-Human Studies: How Much Complexity Is Too Much?
View Session 277. Breakthrough Therapy: One Candle on the Birthday Cake – Are Innovators Enjoying Sweet success or Is the Pathway Not Baked Yet?
Wednesday, June 26
View Session 318. Molecular Predictors of Drug Induced Harm: From Clinical Development to Postmarketing Surveillance
View Session 332. Pharmacometrics: Implications and Impact in Preclinical to Early Phase Development
View Session 339. Drug Shortages: Causes, Current State & Path Forward
View Session 343. Challenges and Strategic Approaches to Biosimilar Development
View Session 360. Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market
View Annual Meeting Student Reflections
EMA Press Release: Pharmacovigilance Risk Assessment Committee: One year of Public Health Promotion and Protection